Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies. (elifesciences.org)

Authors: Lin Y … Sun Y Journal: eLife Published: 2026-06-23 DOI: https://doi.org/10.7554/eLife.109518